|
ANTAGONISM OF VEGA-DRIVEN ANGIOGENESIS
|
5R01CA077357-09
|
$303,039
|
$303,039
|
SENGER, DONALD
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Generation of Antiangiogenic Activity for Cancer Treat.
|
5R01CA098948-05
|
$270,081
|
$202,561
|
SUKHATME, VIKAS
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Long Acting VEGF BInding Proteins for Treating Cancer
|
5R44CA099217-03
|
$335,148
|
$335,148
|
Cox, George
|
BOLDER BIOTECHNOLOGY, INC.
|
|
Women's Health Study: Continued Follow-up
|
5R01CA047988-17
|
$1,666,176
|
$333,235
|
BURING, JULIE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Physicians' Health Study II: Prevention Trial of Vitamins
|
2R01CA097193-06A1
|
$1,550,473
|
$310,095
|
GAZIANO, J
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Carbohydrate-Dependent Adhesion in Normal&Tumor Cells
|
3P01CA071932-10S1
|
$369,509
|
$184,755
|
FUKUDA, MINORU
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
Metalloproteinases in Tumor Neovascularization
|
5R01CA083017-09
|
$285,237
|
$285,237
|
STRONGIN, ALEX
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA030199-27
|
$3,387,817
|
$101,635
|
VUORI, KRISTIINA
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
Attenuation of Radiation-Induced GI Injury by Cultured Myeloid Progenitors
|
1R41CA126604-01
|
$300,000
|
$150,000
|
Christensen, Julie
|
CELLERANT THERAPEUTICS, INC.
|
|
Regulation of Angiogenesis
|
2P01CA045548-21
|
$1,600,000
|
$1,600,000
|
FOLKMAN, JUDAH
|
CHILDREN'S HOSPITAL BOSTON
|
|
Growth Genes, Extracellular Matrix and Angiogenesis
|
5R01CA055833-14
|
$311,052
|
$311,052
|
INGBER, DONALD
|
CHILDREN'S HOSPITAL BOSTON
|
|
CHARACTERIZATION OF NEUROPILIN, A NOVEL VEGF RECEPTOR
|
5R37CA037392-26
|
$676,241
|
$473,369
|
KLAGSBRUN, MICHAEL
|
CHILDREN'S HOSPITAL BOSTON
|
|
Photodynamic Therapy Affects on the Tumor Microenvironment
|
2R01CA031230-23
|
$333,347
|
$166,674
|
GOMER, CHARLES
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA033572-24S1
|
$61,920
|
$1,238
|
KRONTIRIS, THEODORE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA033572-24S2
|
$103,852
|
$2,077
|
KRONTIRIS, THEODORE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA033572-24
|
$2,274,248
|
$45,485
|
KRONTIRIS, THEODORE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Stat3 and anti-VEGF therapy in cancer
|
5R01CA100878-06
|
$285,231
|
$285,231
|
YU, HUA
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Inhibition of VEGF Mediated Angiogenesis by TIMP-3
|
5R01CA106415-03
|
$260,393
|
$260,393
|
ANAND-APTE, BELA
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
ANALYSIS OF Id GENE TARGETS IN TUMOR ENDOTHELIAL CELLS
|
5R01CA100933-04
|
$296,523
|
$296,523
|
MITTAL, VIVEK
|
COLD SPRING HARBOR LABORATORY
|
|
CSHL CANCER CENTER SUPPORT GRANT
|
5P30CA045508-21
|
$4,086,019
|
$163,441
|
STILLMAN, BRUCE
|
COLD SPRING HARBOR LABORATORY
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S1
|
$124,531
|
$1,245
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S3
|
$137,869
|
$1,379
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S4
|
$232,326
|
$2,323
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S5
|
$250,000
|
$2,500
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-43
|
$11,526,509
|
$115,265
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
ALK-1 and Endoglin Signaling in Endothelial Cells
|
3R01CA105255-04S1
|
$54,505
|
$54,505
|
BLOBE, GERARD
|
DUKE UNIVERSITY
|
|
ALK-1 and Endoglin Signaling in Endothelial Cells
|
5R01CA105255-04
|
$262,919
|
$262,919
|
BLOBE, GERARD
|
DUKE UNIVERSITY
|
|
Heat And Radiation Effects On Tumor Microcirulation
|
5R01CA040355-23
|
$305,504
|
$305,504
|
DEWHIRST, MARK
|
DUKE UNIVERSITY
|
|
Endothelial cell molecular alterations in cancer
|
5R33CA094365-04
|
$504,472
|
$504,472
|
KENAN, DANIEL
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Ctr Core Support Grant
|
3P30CA014236-33S1
|
$84,062
|
$3,362
|
LYERLY, HERBERT
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Ctr Core Support Grant
|
5P30CA014236-33
|
$6,558,287
|
$262,331
|
LYERLY, HERBERT
|
DUKE UNIVERSITY
|
|
Gordon Research Conference On Cell Contact And Adhesion
|
5R13CA102013-03
|
$7,000
|
$700
|
GRUNWALD, GERALD
|
GORDON RESEARCH CONFERENCES
|
|
E2F TRANSCRIPTION FACTOR AND TUMOR SUPPRESSION
|
5R01CA063136-15
|
$290,561
|
$290,561
|
CHELLAPPAN, SRIKUMAR
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Moffitt Cancer Center Support Grant
|
2P30CA076292-09
|
$2,780,246
|
$55,605
|
DALTON, WILLIAM
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Moffitt Cancer Center Support Grant
|
3P30CA076292-09S1
|
$124,501
|
$2,490
|
DALTON, WILLIAM
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Moffitt Cancer Center Support Grant
|
3P30CA076292-09S2
|
$192,356
|
$3,847
|
DALTON, WILLIAM
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Moffitt Cancer Center Support Grant
|
3P30CA076292-09S3
|
$178,221
|
$3,564
|
DALTON, WILLIAM
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Growth Factor as Anti-angiogenesis Agents
|
5R01CA106829-04
|
$321,936
|
$321,936
|
SEBTI, SAID
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Regional Oncology Research Center
|
3P30CA006973-45S1
|
$231,549
|
$2,315
|
BAYLIN, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-45S2
|
$126,362
|
$1,264
|
BAYLIN, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
5P30CA006973-45
|
$7,564,613
|
$75,646
|
BAYLIN, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
Inhibition of Angiogenesis by TNP 470 and Ovalicin
|
5R01CA078743-11
|
$364,314
|
$364,314
|
LIU, Jun
|
JOHNS HOPKINS UNIVERSITY
|
|
Cryptic Domains of Collagen-IV in Tumor Growth
|
2R01CA091645-06A2
|
$336,765
|
$168,383
|
BROOKS, PETER
|
MAINE MEDICAL CENTER
|
|
Descriptive Studies and Record Linkage
|
Z01 CP010183
|
$674,691
|
$844
|
Anderson
|
DCEG (NCI)
|
|
Molecular Mechanism of Action of Phorbol Ester
|
Z01 BC 005270
|
$1,250,284
|
$125,028
|
Blumberg, Peter
|
CCR (NCI)
|
|
The Role of JAM-C in Adhesive Interactions of Immune Cells
|
Z01 BC 010663
|
$170,169
|
$68,068
|
Chavakis, Triantafyllos
|
CCR (NCI)
|
|
Crosstalk between inflammation and angiogenesis
|
Z01 BC 010664
|
$63,813
|
$25,525
|
Chavakis, Triantafyllos
|
CCR (NCI)
|
|
Regulation of leukocyte integrins in inflammatory cell recruitment
|
Z01 BC 010790
|
$148,898
|
$59,559
|
Chavakis, Triantafyllos
|
CCR (NCI)
|
|
Diazeniumdiolate Chemistry as a Platform for Designing Nitric Oxide-Based Therapi
|
Z01 BC 005673
|
$776,194
|
$620,955
|
Keefer, Larry
|
CCR (NCI)
|
|
Signal Transduction of Paired Inhibitory Receptors of NK Cells and Macrophages
|
Z01 BC 010300
|
$418,457
|
$83,691
|
McVicar, Daniel
|
CCR (NCI)
|
Total relevant funding to Vascular Disease for this search: $25,037,103
|